SNS-314

SNS-314
Please request pricing for this article.
Request Pricing

Item number Size Datasheet Manual SDS Delivery time Quantity Price
SYN-1081-M001 1 mg -

3 - 9 business days*

106.00€
SYN-1081-M005 5 mg -

3 - 9 business days*

172.00€
SYN-1081-M010 10 mg -

3 - 9 business days*

263.00€
SYN-1081-M050 50 mg -

3 - 9 business days*

856.00€
SYN-1081-M100 100 mg -

3 - 9 business days*

-
 
Soluble in DMSO or ethanol. Aurora kinases constitute a family of serine-threonine kinases that... more
Product information "SNS-314"
Soluble in DMSO or ethanol. Aurora kinases constitute a family of serine-threonine kinases that are strongly associated with cancer. Aurora A and B are essential in mitosis. Perturbation of their activity leads to multiple defects in mitosis including aberrant centrosome duplication, misalignment of chromosomes, inhibition of cytokinesis, and disruption of the spindle checkpoint. The role of Aurora C is unclear, however, Aurora C can complement Aurora B kinase activity in mitosis. SNS-314 is an ATP-competitive, selective, and potent nanomolar inhibitor of aurora kinases in vitro. A cocrystal structure of SNS-314 with Aurora A confirms that SNS-314 engages the purine-binding pocket of Aurora. SNS-314 inhibits cellular proliferation in the HCT116 colorectal carcinoma cell line with an EC50 of ~5nM. Analysis of DNA content and indirect immunofluoresence demonstrates that SNS-314 induces defects in cytokinesis and spindle checkpoint that are consistent with Aurora kinase inhibition. Phosphorylation of Histone H3 on serine 10, a known Aurora B cellular target, is inhibited with an EC50 of ~9nM following treatment of cells with SNS-314. Administration of SNS-314 to HCT116 tumor bearing mice potently suppresses tumor growth. Analysis of SNS-314 treated tumors confirms that the anti-tumor activity is consistent with Aurora kinase inhibition. SNS-314 is a potent small-molecule inhibitor of Aurora kinase that is being developed as a novel anti-cancer therapeutic agent Target: Aurora A , Kinase Group: Other , Substrate: Serine-Threonine
Keywords: SNS314
Supplier: SYNkinase
Supplier-Nr: 1081

Properties

Application: Aurora inhibitor
MW: 430,9 D
Formula: C18H15ClN6OS2
Purity: >95%
Format: Solid

Database Information

CAS : 1057249-41-8| Matching products
KEGG ID : K11480 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "SNS-314"
Write a review
or to review a product.
Viewed